This SOP establishes the requirements for conducting drug recalls in sterile compounding—including traceability of ingredients and preparations, classification of recalls (Class I–III), notification of patients and prescribers, quarantine of affected products, documentation of lot numbers, recall letters, investigation of causes, corrective training, and regulatory reporting—to ensure patient safety, product accountability, and compliance with FDA, USP <797>, and board of pharmacy standards.